Shares outstanding · 2011–2025
Neurocrine Biosciences shares outstanding
100M+0.7% · FY2025
Neurocrine Biosciences (NBIX) reported 100M in shares outstanding for fiscal 2025, +0.7% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252026-02-04 | 100M | +0.7% | Open → |
| FY20242025-02-05 | 99.7M | +0.2% | Open → |
| FY20232024-02-05 | 99.5M | +3.0% | Open → |
| FY20222023-01-31 | 96.6M | +1.4% | Open → |
| FY20212022-02-07 | 95.2M | +1.4% | Open → |
| FY20202021-01-29 | 93.9M | +1.8% | Open → |
| FY20192020-01-31 | 92.3M | +1.6% | Open → |
| FY20182019-02-01 | 90.8M | +1.7% | Open → |
| FY20172018-02-02 | 89.3M | +2.5% | Open → |
| FY20162017-02-01 | 87.1M | +0.8% | Open → |
| FY20152016-02-01 | 86.5M | +12.0% | Open → |
| FY20142015-01-26 | 77.2M | +13.8% | Open → |
| FY20132014-01-24 | 67.8M | +1.9% | Open → |
| FY20122013-01-31 | 66.5M | +0.4% | Open → |
| FY20112012-01-31 | 66.2M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +3.0%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neurocrine Biosciences shares outstanding |url=https://companiesranked.com/en/company/neurocrine-biosciences/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neurocrine Biosciences shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/neurocrine-biosciences/shares-outstandingBibTeX
@misc{companiesranked-en-company-neurocrine-biosciences-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Neurocrine Biosciences shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neurocrine-biosciences/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000914475-26-000007 · February 11, 2026
{{cite web |title=Neurocrine Biosciences shares outstanding — 10-K (0000914475-26-000007) |url=https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.